CLIN2 Awards: Funding Opportunity for Clinical Trials supports clinical teams testing stem cell-based or genetic therapies in phase 1, 2, or 3 trials to address serious unmet medical needs.
The CLIN2 application period has changed from open to closed. The funder also removed the October 23, 2026 mandatory consultation deadline and instructions for restarting previously unsubmitted applications.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical investigation to move promising concepts toward potential patient impact.
CIRM’s Discovery Stage Research program funds collaborative, innovative basic research to advance breakthroughs in regenerative medicine and stem cell biology, focusing on foundational science and early-stage discoveries.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Preclinical Development supports researchers developing stem cell-based and genetic therapies, funding candidate optimization, preclinical studies, and trial startup to advance toward first-in-human trials.
Early Clinical Investigator Awards support postdoctoral trainees in Oregon conducting clinical or translational research to build independent research careers and lay the groundwork for future funding.